Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Neuren secures European patent for drug aimed to treat incurable brain disorders
    • News

    Neuren secures European patent for drug aimed to treat incurable brain disorders

    Australian biopharmaceuticals developer Neuren Pharmaceuticals (ASX: NEU) has been granted a patent from the European Patent Office covering NNZ-2591, a world-first drug being developed to treat three neurodevelopmental disorders which affect children, and are currently incurable.  The granting of the new patent is the third jurisdiction to do so for Neuren with the same application

    Read More
    Public
  • ASX IPO Watch: December Listings of Interest – 13 Seeds, Openpay, Founders First, Tyro & OpenLearning
    • Opinion

    ASX IPO Watch: December Listings of Interest – 13 Seeds, Openpay, Founders First, Tyro & OpenLearning

    2019 has been a mixed year for IPOs but here are a few companies intending to list on the ASX in December which may be worth keeping an eye on.  13 Seeds Limited (Proposed ASX: 13S) Established in 2016, 13 Seeds Limited are a Tasmanian-based, hemp superfood and skincare nutraceutical company.  The company are proposed

    Read More
    Public
  • Amaysim acquires Jeenee Mobile, increases recurring subscribers to 698k
    • News

    Amaysim acquires Jeenee Mobile, increases recurring subscribers to 698k

    Telecommunications provider amaysim (ASX: AYS) has strengthened its recurring mobile subscriber base through the acquisition of Jeenee Communications and its 41,700 subscribers.  The purchase of the privately-held mobile virtual network operator (MVNO) for total consideration of $7.8 million will take amaysim’s total recurring mobile subscriber base to 698,600 total users with Jeenee customers to be

    Read More
    Public
  • A not so merry Christmas? – Lending growth slows
    • Opinion

    A not so merry Christmas? – Lending growth slows

    Despite the recent mini boom in home prices, higher auction clearance rates, and bullish media commentary, the sentiment is simply not showing up in credit statistics released today. Investor home lending growth is slightly in negative territory and personal credit growth is further accelerating its decline with negative 4.74% annual growth. Business lending growth is

    Read More
    Public
  • Quantify Tech secures $500k order to turn apartments into SmartHomes
    • News

    Quantify Tech secures $500k order to turn apartments into SmartHomes

    Australian tech manufacturer Quantify Technology (ASX: QFY) has secured an order in excess of $500,000 for their qDevices which will be installed in three apartment buildings, converting them into SmartHomes where lighting and sound will be adjustable by occupants via voice, app and touch.  The Heads of Agreement (HoA) is with Sydney based building developer

    Read More
    Public
  • Retail sales beware: Annual change in GST receipts turn negative
    • Opinion

    Retail sales beware: Annual change in GST receipts turn negative

    Finance.gov.au released components of taxation revenue for the month of October 2019. Combining these figures into a time series dating back to 2014, we get to look at the 12 months annual changes in various Government tax receipts. Annual Goods and Services tax (GST) to the end of October 2019 came in at $65.9 Billion,

    Read More
    Public
  • «
  • ‹
  • 639
  • 640
  • 641
  • 642
  • 643
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.